Structure Therapeutics (GPCR) Free Cash Flow (2022 - 2026)
Quarterly Free Cash Flow rose 126.74% to $14.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$156.5 million through Mar 2026, down 14.88% year-over-year, with the annual reading at -$223.1 million for FY2025, 89.18% down from the prior year.
Structure Therapeutics' Free Cash Flow history spans 5 years, with the latest figure at $14.1 million for Q1 2026.
- Free Cash Flow came in at $14.1 million for Q1 2026, up from -$63.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $14.1 million in Q1 2026 to a low of -$63.2 million in Q4 2025.
- The 5-year median for Free Cash Flow is -$20.7 million (2023), against an average of -$26.7 million.
- Year-over-year, Free Cash Flow plummeted 157.93% in 2025 and then soared 126.74% in 2026.
- Structure Therapeutics' Free Cash Flow stood at -$12.1 million in 2022, then plummeted by 94.96% to -$23.6 million in 2023, then crashed by 54.69% to -$36.5 million in 2024, then tumbled by 73.21% to -$63.2 million in 2025, then surged by 122.24% to $14.1 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Free Cash Flow are $14.1 million (Q1 2026), -$63.2 million (Q4 2025), and -$52.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 848.30 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 14.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.05 Mn |
| Mar 31, 2026 | 14.05 Mn |
| Dec 31, 2025 | -63.19 Mn |
| Dec 31, 2025 | -63.19 Mn |
| Sep 30, 2025 | -52.57 Mn |
| Sep 30, 2025 | -52.57 Mn |
| Jun 30, 2025 | -54.79 Mn |
| Jun 30, 2025 | -54.79 Mn |
| Mar 31, 2025 | -52.54 Mn |
| Mar 31, 2025 | -52.54 Mn |
| Dec 31, 2024 | -36.48 Mn |
| Dec 31, 2024 | -36.48 Mn |
| Sep 30, 2024 | -20.38 Mn |
| Sep 30, 2024 | -20.38 Mn |
| Jun 30, 2024 | -26.82 Mn |
| Jun 30, 2024 | -26.82 Mn |
| Mar 31, 2024 | -34.24 Mn |
| Mar 31, 2024 | -34.24 Mn |
| Dec 31, 2023 | -23.58 Mn |
| Dec 31, 2023 | -23.58 Mn |
| Sep 30, 2023 | -20.68 Mn |
| Sep 30, 2023 | -20.68 Mn |
| Jun 30, 2023 | -16.89 Mn |
| Jun 30, 2023 | -16.89 Mn |
| Mar 31, 2023 | -20.31 Mn |
| Mar 31, 2023 | -20.31 Mn |
| Dec 31, 2022 | -12.10 Mn |
| Dec 31, 2022 | -12.10 Mn |
| Sep 30, 2022 | -10.55 Mn |
| Sep 30, 2022 | -10.55 Mn |
| Jun 30, 2022 | -10.04 Mn |
| Jun 30, 2022 | -10.04 Mn |
| Mar 31, 2022 | -13.58 Mn |
| Mar 31, 2022 | -13.58 Mn |